Only slight impact of predicted replicative capacity for therapy response prediction.

by Hendrik Weisser, André Altmann, Saleta Sierra, Francesca Incardona, Daniel Struck, Anders Sönnerborg, Rolf Kaiser, Maurizio Zazzi, Monika Tschochner, Hauke Walter, Thomas Lengauer
Published 2010-02-01

Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.

by Monika Tschochner, Shay Leary, Don Cooper, Kaija Strautins, Abha Chopra, Hayley Clark, Linda Choo, David Dunn, Ian James, William M Carroll, Allan G Kermode, David Nolan
Published 2016-01-01